The FDA approves Bracco Diagnostics' Lumason imaging agent for hard-to-see cardiac ultrasounds.
The FDA approved Bracco Diagnostics' Lumason agent for patients whose ultrasound image of the heart are hard to see with ultrasound waves.
Medtronic says the FDA approved its CapSureFix Novus MRI SureScan 5076 pacemaker lead for full-body MRI scans in patients with its Advisa MRI or Revo MRI SureScan pacemakers.
Medtronic (NYSE:MDT) said today that the FDA approved its CapSureFix Novus MRI SureScan 5076 lead in MRI scans for patients with a Medtronic dual-chamber MR-conditional pacemaker.
Medtronic will begin marketing Ortho Kinematics' Vertebral Motion Analysis as an alternative to X-ray tests.
GE Healthcare accuses one of its Wisconsin-based engineers of copying millions of confidential files before landing a job at a rival company in China.
Officials at GE Healthcare (NYSE:GE) filed a lawsuit against one of their Waukesha, Wisc., engineers after finding out that he copied millions of sensitive files that the company says were not necessary for his role.
Ohio-based Navidea Biopharmaceuticals allies with a Chinese drug group to pursue regulatory approval and prepare distribution in the emerging market.
Navidea Biopharmaceuticals (NYSE:NAVB) is preparing major moves in China with a new alliance that aims to bring its Lymphoseek imaging agent to the country.
GE Healthcare wins FDA approval for its SenoClaire 3D breast tomosynthesis system, a device that could displace digital mammography as the major technology for breast cancer screening.
Imaging giant GE Healthcare (NYSE:GE) won FDA approval for its 3D breast tomosynthesis imaging system, MassDevice.com has learned.
All new da Vinci systems will ship with Intuitive Surgical's newly cleared Firefly blood and tissue imaging technology.